About Doliam
Doliam is a venture capital firm founded in 1991. It is primarily based out of Maisons Laffitte, France. As of Jan 2026, Doliam has invested in 4 companies. It primarily invests in Seed round in France based startups. Its investments are spread across a wide range of sectors from HealthTech to Life Sciences and Enterprise Applications. Most recently it participated in the $***** Series C round of FineHeart LAUAK PORTUGAL co-invest with Doliam, sharing a substantial percentage of its portfolio. Doliam has team of 8 people including 5 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series B
Portfolio Soonicorns
Doliam's List of All Investments
Doliam has a portfolio of 4 companies. Their most notable investments are in Neurallys and FineHeart.Their portfolio spans across and France. They have invested in HealthTech, Life Sciences, Enterprise Applications and 1 other sectors, across stages such as Seed, Series B stages. Here is the list of all investments by Doliam:1. FineHeart
Developer of an implantable cardiovascular device for treating heart failures. The device provides long-term circulatory assistance. The I.C.O.M.S. (Implantable Cardiac Output Management System) is synchronized to heart innate contraction and helps to manage heart failure disease.
Key facts about FineHeart
- Founded Year: 2010
- Location: Pessac (France)
- Stage: Series C
- Total Funding till date: $51.9M
- Employee Count: 87 as on Jun 30, 2026
- Investors: Verve Ventures, Broadview Ventures and 16 Others
- Latest Funding Round: Series C, Jan 09, 2026, $*****
- Highlight: Editors' Pick
2. Iconeus
Digital animal brain imaging and analysis device for researchers. The company has developed functional neuroimaging systems for preclinical neuroscience research and drug discovery industries. They have developed an imaging modality based on blood flow imaging. It enables to detection of neuronal activation in the whole brain.
Key facts about Iconeus
3. Neurallys
Neurallys is developing a device for the treatment of Hydrocephalus (caused by an accumulation of cerebrospinal fluid within the brain resulting in abnormal intracranial pressure). It is an intelligent sensor, which continuously measures intracranial pressure in hydrocephalus patients who have an implanted shunt system. It helps detect valve malfunctions and thereby avoid exploratory surgical intervention.
Key facts about Neurallys
- Founded Year: 2016
- Location: Paris (France)
- Stage: Seed
- Total Funding till date: $847K
- Employee Count: 1 as on Jun 30, 2026
- Investors: EIT Health, Doliam and 1 Other
- Latest Funding Round: Seed, Apr 17, 2019, $*****
4. SentinHealth
Sentihealth provides an AI-based monitoring platform for hospitals. The software monitors daily heart activity and other early signs of evolving heart failure from the digestive tract.
Key facts about SentinHealth
Doliam's Year-on-Year Investment Trends
Doliam has invested in 4 companies over the last 7 years, with an average of 0 new investment annually in the last 5 years. As of Jan 2026, it has made 1 investment in this year. Its most recent first time investment was in FineHeart and most recent follow-on round was in FineHeart.Doliam's Investments by Stage
Doliam has made 1 investment in Seed stage with an average round size of $847K and 1 investment in Series B stage with an average round size of $6.77M.Doliam's Investments by Sector
Doliam has a diverse portfolio, with companies operating in the Life Sciences and HealthTech. Notably, it has invested in 4 Enterprise (B2B) companies, 3 Tech companies, 2 Software companies and 2 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 2 |
HealthTech | 1 |
Note: We have considered here, only first round of investments
Doliam's Investments by Geography
Doliam has made most investments in France (2).Doliam's recent investments
Doliam has made 1 investments in 2026 so far - FineHeart.Here are the most recent investments by Doliam:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jan 09, 2026 | France | Series C | 3676 | ||
Dec 15, 2021 | France | Series B | 5927 | [+1] | |
Apr 17, 2019 | France | Seed | 1487 | - |
Team profile of Doliam
Doliam has a team of 8 members including 5 Partners and 1 Venture Partner located in France. Doliam's team does not sit on the board of any company as of now.Here is a list of all team members in Doliam:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Paris | - | ||
Partner | Tours | - | - | |
Partner | France | - | - | |
Partner | Tours | - | ||
Partner | Paris | - | - | |
Venture Partner | Tours | - |
Co-investors of Doliam
Over the past 7 years, 16 investors have co-invested in Doliam's portfolio companies. This includes only funds.
- Invested before Doliam: Broadview Ventures, Aquiti Gestion and 8 others have invested in rounds before Doliam. There is 1 company where Broadview Ventures has invested before Doliam and 1 company where Aquiti Gestion has invested before Doliam.
- Top Co-investors of Doliam: LAUAK PORTUGAL entered a company along with Doliam.
- Invested after Doliam: A total of 5 investors have invested in Doliam's portfolio after their investments. Top Investors include EIC Fund (1 company), Groupe Pasteur Mutualité (1 company) and Etchart (1 company).
Recent News related to Doliam
•
FineHeart Raises €35M in Series C First Closing; Receives €48M in GrantsFinSMEs•Jan 09, 2026•Naco, IRDI Capital Investissement, Doliam, Groupe Pasteur Mutualité and 3 others
•
FineHeart completes a fundraising of 21 million euros to test its mini heart pump on humansusine-digitale.fr•Dec 15, 2021•FineHeart, Verve Ventures, LAUAK PORTUGAL, Doliam
